Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R
2
CHADS
2
Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”
2017 ◽
Vol 120
(10)
◽
pp. 1837-1840
◽
Keyword(s):
2015 ◽
Vol 170
(4)
◽
pp. 675-682.e8
◽
2010 ◽
Vol 159
(3)
◽
pp. 340-347.e1
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 119
(12)
◽
pp. 1989-1996
◽
Keyword(s):
Keyword(s):